• Mashup Score: 0

    The VA Lung Precision Oncology Program (LPOP), a component of the VA National Precision Oncology Program, aims to give VA clinicians a range of tools to proactively address and treat lung cancer in Veterans. Precision oncology uses patients’ unique genetic profiles to tailor individualized treatment and connect them with new therapies through clinical trials.

    Tweet Tweets with this article
    • For our team at the Birmingham VA Oncology, every day is Veteran’s day! What a privilege to serve those who served us 🇺🇸🙏🏽 #VeteransDay2022 Thank you ALL for your service!@HemOncWomenDocs So grateful to be part of this @VAResearch initiative #Lcsm https://t.co/hyNZHWxwtD https://t.co/gfG22CjMgK

  • Mashup Score: 2

    Free to Breathe Anywhere Walk to raise funds for lung cancer research. Get a team together and walk wherever you are!

    Tweet Tweets with this article
    • Be the change you want to see!💕 All ready to walk this Sat to raise awareness about #lcsm in Alabama. #FreetoBreathe 🫁 Walk with me, walk anywhere to support #lcsm research! This is for all my patients and loved ones affected by this deadly cancer 🙏🏽 https://t.co/9UpE1GCBff https://t.co/5qn7udNVeC

  • Mashup Score: 7
    092222-N-IP-ESLC - 3 year(s) ago

    IDEOlogy Health is hosting non-promotional, unbiased roundtable discussions for oncologists to stay up-to-date on the latest clinical data and learn from one another. Please register by filling out the form if you’d like to attend.Date: Thursday, September 29thTime: 6:00 PM CST Speaker: Devika Das, MD Venue: Ocean Restaurant, 1218 20th St S, Birmingham, AL 35205

    Tweet Tweets with this article
    • If you are interested in a clinical discussion on “Small cell lung cancer” - join me tomorrow ( hybrid) to register ⬇️ @IDEOlogyHealth #lcsm In person: https://t.co/lAZfWbhvv2 Or virtually https://t.co/mMGh5j4NEf https://t.co/D5YR5WDeF8

  • Mashup Score: 0

    AuthorsWendi WaughSOMC Cancer Center, Portsmouth, OHWendi Waugh, Devika Govind Das, Nancy N Thomas, Elana Plotkin, Ravi Salgia, Alexander I. Spira, Mark A. Socinski, Percy Lee, Matthew Smeltzer, Joseph Kim, Leigh BoehmerOrganizationsSOMC Cancer Center, Portsmouth, OH, University of Alabama at Birmingham, Birmingham, AL, Saint Francis Cancer Center, Tulsa, OK, Association of Community Cancer…

    Tweet Tweets with this article
    • Multi institutional QI work supported by @ACCCBuzz 📍 Lessons learned, included the need to educate/raise awareness about early identification of IrAEs related to CPI, specially in ED and Primary care settings. #lcsm #ASCOQLTY22 @ASCO #OncMedEd https://t.co/X0FDemwLPM https://t.co/VtyP7r3Xbm

  • Mashup Score: 2

    Vikas Mehta, MD, MPH, proposes instituting time to treatment initiation as an oncology, site-specific quality measure, looking at time from diagnosis to first treatment, and establishing metrics around that time point as a means to improve oncologic outcomes, especially for disparate populations.

    Tweet Tweets with this article
    • I can absolutely get behind this metric but would modify it to include “appropriate” treatment as a balance measure as timeliness a check list item alone should not compromise appropriate staging, biomarker testing etc #Lcsm #Hncsm #QI #Safety https://t.co/0XzehVYBaB https://t.co/WAQpofaM1I

  • Mashup Score: 0

    Mid-career women are often surprised by the levels of bias and discrimination they encounter in the workplace, especially if they’ve successfully avoided it earlier in their careers. After speaking to 100 senior women executives, the authors identified three distinct kinds of bias and discrimination faced by mid-career women: unfair assumptions, unhelpful attention, and unequal access. They…

    Tweet Tweets with this article
    • Cc: @WIMChatSunday @HemOncWomenDocs #WomenInMedicine #WomeninLeadership https://t.co/WPUVCq0gDj